Etoricoxib, sold under the brand name Arcoxia, is a selective COX-2 inhibitor developed and commercialized by Merck. It is approved in 63 countries worldwide as of 2007, except the …

2023年3月12日 · Arcoxia (etoricoxib) is used to treat osteoarthritis and rheumatoid arthritis. Includes Arcoxia side effects, interactions and indications.

2022年10月26日 · Etoricoxib eases pain and swelling (inflammation) in conditions like osteoarthritis, rheumatoid arthritis and ankylosing spondylitis, and it may also be used for short …

Etoricoxib works by blocking the enzyme COX-2, which produces prostaglandins that cause pain and inflammation. By inhibiting COX-2, it helps reduce pain, swelling, and inflammation, …

Etoricoxib is a nonsteroidal anti-inflammatory drug (NSAID) used to relieve pain and inflammation associated with conditions such as osteoarthritis, rheumatoid arthritis, ankylosing spondylitis, …

Etoricoxib is a selective cyclo-oxygenase enzyme (COX-2) inhibitor that reduces the production of prostaglandins from arachidonic acid. Prostaglandins affect our physiological processes, such …

2024年6月8日 · It is specifically a selective COX-2 inhibitor, which helps in reducing pain and inflammation by blocking the COX-2 enzyme responsible for the production of prostaglandins. …